Executive remuneration
The table below summarises the different remuneration elements of the executive directors’ and Executive Committee
members’ packages.
Summary of executive remuneration structure
| Element |
Type |
Objective |
Basis for determination |
Delivery method |
| Guaranteed
package |
Fixed |
Reflects
individual
contribution
and market
value relative
to role. |
Based on the complexity of the role, market value,
the employee’s personal performance and
contribution to Netcare’s overall performance. |
Monthly payments
in cash after
deducting
contributions to
retirement funding
and medical aid. |
| Short-term
incentives |
Variable |
Individual
and Company
performance
related. |
Combination of Company-specific financial targets,
operational and strategic objectives, as well as
individual performance targets. |
Annual payment in
cash subsequent to
annual review. |
| Medium-term
incentives |
Variable |
Alignment of
shareholder
interests with
that of
executives
and retention
of executives. |
Linked to the Netcare share price and takes into
account a minimum return over and above inflation
and accordingly includes a suitable stretch target
for executives. |
Biannual payments
if minimum future
Netcare share price
(strike price) has
been reached. |
| Long-term
incentives |
Variable |
Attracting
and retaining
executives. |
Netcare Share Incentive Scheme
Equity share-based scheme with share options
vesting in equal amounts over five years
commencing on the second anniversary of the
grant date. |
Delivered in
Netcare shares
over vesting period. |
| |
Variable
based on
performance
and
retention |
Attracting
and retaining
executives. |
FSP
Combination of performance-based share awards
which are fixed to clearly defined performance
targets which, if not met, result in the forfeiture of
shares, and a retention-based award which serves
to incentivise the executive to remain in the employ
of the Company. Consistent with the rules of the
scheme and the decision of the Remuneration
Committee, the split in shares is awarded in favour
of the performance-based targets as opposed to
the retention-based awards. |
Delivered in
Netcare shares
over vesting period
with dividends
being earned over
the period. |
Fixed remuneration
Guaranteed package
Netcare aims to remunerate its
employees at the market median while
taking into account individual
responsibilities and performance.
Guaranteed remuneration packages are
benchmarked against the market every
three to four years. Guaranteed pay
includes salary, employee benefits (such
as retirement funding and medical aid
contributions), Group life cover, funeral
cover and disability insurance.
Guaranteed remuneration is reviewed
annually and increases take effect in
March. Annual increases are
performance and market related, taking
into account factors such as the
prevailing economic conditions, inflation,
Company performance and affordability.
Details of the executive directors and
prescribed officers’ guaranteed
package can be found in note 37 of the
Group annual financial statements.
Variable pay
Short-term incentives
Executives and senior management
participate in an annual short-term
incentive plan which delivers a cash
bonus based on Netcare’s
achievement of financial targets
and on strategic and personal
performance objectives set annually.
The Remuneration Committee approves
the incentive targets annually, which
are based on a combination of
the following broad Company measurements combined with specific
strategic objectives in SA:
| • |
A “gateway” to participation for all
participants of an improvement to
SA headline earnings per share of
a minimum of 12.5% on the
previous year; |
| • |
Earnings before interest, tax,
depreciation and amortisation
(EBITDA); |
| • |
Cash conversion and other financial
and efficiency parameters; |
| • |
Patient care feedback; |
| • |
Staff satisfaction feedback; |
| • |
Sustainability initiatives; and |
| • |
Transformation targets. |
The maximum bonuses that may be
earned by executives and senior
management as a percentage of total
annual guaranteed package (excluding
company contributions to retirement
funding and medical aid as well as
cellular phone allowances) are as
follows:
| • |
Group CEO – 75% |
| • |
Executive Committee members – 60% |
| • |
Other executives/senior
management – 50% |
Medium-term incentives
The Executive Leveraged Bonus
Scheme is a core element of the
retention strategy of executives as it
aligns executives’ interests with those
of shareholders. The Remuneration
Committee has, from time to time,
approved awards under this scheme.
The current scheme ran until
30 November 2012 and is not
envisaged to be repeated.
Details of this scheme can be found in note 38 to the Group annual financial
statements.
Details of the executive directors’ and
prescribed officers’ phantom shares,
vesting dates and strike prices are presented in note 37 to the Group
annual financial statements.
Long-term incentives
Netcare Share Incentive Scheme
Long-term incentives are offered
through participation in the Netcare
Share Incentive Scheme, intended to
reward improved, sustainable business
performance and create alignment with
shareholder interest over the longer
term. Executives and senior
management are given the opportunity
to own shares in Netcare. Share
options granted vest in equal amounts
over five years commencing on the
second anniversary of the grant date.
Share options are granted at the
discretion of the Remuneration
Committee taking into account
management’s recommendations.
Details of the Netcare Share Incentive
Scheme can be found in note 38 to the
Group annual financial statements.
Details of the executive directors’ and
prescribed officers’ share options in
terms of the Netcare Share Incentive
Scheme are presented in note 36 to the
Group annual financial statements.
Forfeitable Share Plan (FSP)
The FSP provides greater benefits that
are commensurate with recommended
governance practice, when compared
to the current schemes in place. The
most significant benefit is the ability to
derive dividends, which addresses
immediate retention risk. The scheme is
also characterised by strictly monitored
performance targets. The FSP has
been introduced as a long-term
incentive for selected employees
(participants) of the Company and
remains subject to a maximum
aggregate number of shares which
may be allocated to designated
participants.
Excepting the applicable securities
transfer tax, and any associated tax
and/or administrative costs payable,
the participant will not be liable for any costs associated with shares awarded
under the FSP.
The number of forfeitable shares subject
to an FSP award made to an employee,
and the mix between performance
shares and retention shares, will
primarily be based on the employee’s
total cost to company, grade,
performance, retention requirements
and market benchmarks as determined
by the Remuneration Committee.
In the event of termination or
resignation of an employee, the FSP
awards will be forfeited in its entirety
and all rights will lapse immediately.
However, the Remuneration Committee
is entitled, in its sole and absolute
discretion, to determine in writing that
all or any part of the FSP awards is not
forfeited. All FSP awards not
subsequently issued to participants
will revert to the FSP.
Dilution
The potential dilution that could occur
if all the share options are implemented
under the Netcare Share Incentive
Scheme is addressed in note 30 to the
Group annual financial statements.
Service contracts
Executive directors are not employed
on fixed-term contracts and have
standard employment service
agreements with current notice
periods of three months. RH Friedland
is restrained from competing with
Netcare for a six-month period should
he terminate his employment with
the Company.
Executive directors’ remuneration
The remuneration relating to the
Company’s prescribed officers is in
terms of the requirements of the
Companies Act No 71 of 2008.
Summarised details of the executive
directors’ and prescribed officers’
remuneration can be found in the
table on the below.
Further details of the executive
directors’ and prescribed officers’
remuneration can be found in note 37 to the Group annual financial statements.
| Executive and prescribed officers’ remuneration |
|
| R000 |
Guaranteed
package |
|
Short and
mediumterm
incentives1 |
|
Total
2012 |
|
Total
2011 |
|
| Executive directors |
|
|
|
|
|
|
|
|
| RH Friedland2 |
6 798 |
|
5 000 |
|
11 798 |
|
11 686 |
|
| KN Gibson3 |
2 836 |
|
1 250 |
|
4 086 |
|
|
|
| Prescribed officers |
|
|
|
|
|
|
|
|
| Prescribed officer A |
2 631 |
|
1 400 |
|
4 031 |
|
3 669 |
|
| Prescribed officer B |
2 861 |
|
1 500 |
|
4 361 |
|
4 151 |
|
| Prescribed officer C |
2 631 |
|
1 300 |
|
3 931 |
|
3 899 |
|
| Prescribed officer D4 |
202 |
|
|
|
202 |
|
326 |
|
Non-executive directors’
remuneration
Non-executive directors receive a fixed
level of remuneration for their services
based on their participation in Board
meetings and other committees. King
III requires non-executive directors to
be paid an attendance fee and a base
fee. Netcare has elected to pay the
non-executive directors a fixed fee for
services rendered, on the basis that
the services of directors extend beyond
the boardroom and are therefore
not confined to attendance at meetings.
Non-executive directors do not
qualify for participation in any share
or incentive schemes.
The remuneration of non-executive
directors is reviewed annually by
the Remuneration Committee and
recommendations for increases are
made to shareholders at the annual
general meeting for consideration
and approval.
The non-executive directors’ fees for
the year ended 30 September 2012
are shown in the table on the right,
together with the fees for the year
ended 30 September 2011, and the
proposed fees for the year ending
30 September 2013. The average
increase is approximately 6% which is
consistent with the increasing demands
faced by non-executive directors in respect of personal liability and
ongoing regulatory demands.
Further details of payments made to
non-executive directors for the years
ended 30 September 2012 and 2011
can be found in note 37 to the Group
annual financial statements.
| Non-executive directors’ remuneration |
|
| Board/Committee position |
2013
R000 |
|
2012
R000 |
|
2011
R000 |
|
| Payable per annum |
|
|
|
|
|
|
| Board |
|
|
|
|
|
|
| Chairman |
955 |
|
900 |
|
850 |
|
| Member |
490 |
|
460 |
|
430 |
|
| Audit Committee |
|
|
|
|
|
|
| Chairman |
160 |
|
150 |
|
140 |
|
| Member |
128 |
|
120 |
|
110 |
|
| Remuneration Committee |
|
|
|
|
|
|
| Chairman |
128 |
|
120 |
|
110 |
|
| Member |
90 |
|
85 |
|
80 |
|
| Risk Committee |
|
|
|
|
|
|
| Chairman |
128 |
|
120 |
|
110 |
|
| Member |
90 |
|
85 |
|
80 |
|
| Nominations Committee |
|
|
|
|
|
|
| Chairman |
128 |
|
120 |
|
110 |
|
| Member |
90 |
|
85 |
|
80 |
|
| Social and Ethics Committee5 |
|
|
|
|
|
|
| Chairman |
128 |
|
120 |
|
110 |
|
| Member |
90 |
|
85 |
|
80 |
|
| Quality Leadership Committee |
|
|
|
|
|
|
| Chairman |
159 |
|
150 |
|
140 |
|
| Member |
127 |
|
120 |
|
110 |
|
| Payable per meeting |
|
|
|
|
|
|
| Ad hoc committees |
32 |
|
30 |
|
27 |
|
1 The short-term incentives include the amounts approved in respect of the 2011 financial year
which are payable in the following year.
2 RH Friedland has contributed in excess of 20% of his post-tax remuneration for the year
to a variety of charitable organisations and causes or to individuals in need of assistance.
3 Appointed 10 November 2011.
4 Effective 1 August 2011 and became executive director with effect 10 November 2011.
5 Previously Transformation Committee.
Summary of UK remuneration
structure
The Remuneration Committee is
currently chaired by Peter Warrener.
The Committee reviews and sets
General Healthcare Group’s (GHG)
remuneration strategy, salary and
benefit levels across GHG, to ensure
competitiveness of remuneration. It
also monitors the management of
equity arrangements in place.
The remuneration elements in the
UK consist of the following:
Guaranteed package
The guaranteed package is similar
to that of SA. The guaranteed
remuneration is reviewed annually
and increases take effect in October.
Short-term incentives
The short-term incentives are similar
to that of SA.
The Committee approves the incentive
targets annually, which are based on a
combination of the following four key
UK measurements combined with
specific strategic objectives:
| • |
Revenue; |
| • |
Earnings before interest, tax,
depreciation and amortisation
(EBITDA); |
| • |
Cash; and |
| • |
Patient satisfaction scores. |
The maximum bonuses that can be
earned by executives and management
as a percentage of total guaranteed
package excluding company contributions
to retirement funding and medical
insurance is as follows:
| • |
CEO – 75% |
| • |
Executive Committee members – 50% |
| • |
Cash; and |
| • |
Senior management – 50% |
Long-term incentives
Two equity-based long-term incentive
programmes were in place for senior
executives, both of which are now fully
vested. A new cash-based long-term
incentive scheme to cover the senior
leadership in the UK has recently
been approved by the Remuneration
Committee.